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Studies about risk factors for mortality in burn children are scarce. We  conducted this
study  to evaluate the risk factors for mortality in pediatric burn patients. We  included 110
patients.  Mean age was 31.5 months (range: 1 to 204). The burn surface was between 1% and
95%(median  27%) Type of burn was: A or superﬁtial in 39 patients (36%), AB or intermediate in
19 (17%), and B or full thickness in 52 (47%). Inhalatory injury was present in 52 patients (47%).
Invasive procedures were: venous catheter, 90 patients (82%), arterial catheter, 83patients
(75.5%),  urinary catheter, 86 patients (78%), and mechanical ventilation, 75 patients (68%). In
84 patients, 128 infections were diagnosed. in 53 cases (48%). Multiresistant Pseudomonas
aeruginosa  and Acynetobacter baumannii were the most common organisms isolated. The
median length of hospital stay was 33 days (r: 8-139 days). Seventeen patients (15%) died and
14 of them of infection-related causes. Age≤ <4 years, Garcés 4, full thickness burn, ≥ 40%
burn  surface, presence of inhalatory syndrome, use of venous catheter, arterial catheter,
urinary  catheter and mechanical ventilation, positive blood cultures, colistin use in doc-
umented multiresistant infections, antifungal use and graft requirement, were identiﬁed
as  risks factors for mortality in the univariate analysis. By multivariate analysis: age ≤4
years,  Garcés 4, colistin use in multiresistant infections, mechanical ventilation and graft
requirement  were independent variables related with mortality.Conclusions:  In this series of burn children age ≤ 4 years, Garces index score 4, colistin use in
documented multiresistant infections, mechanical ventilation and graft requirement were
identiﬁed as independent variables related with mortality.
13 EIntroduction
Burns are very frequent and affect approximately 1% of the
general  population every year.1
The immunocompromising effects of burns, hospital stay;
© 20diagnostic  and therapeutic procedures put these patients at
increased risk of morbidity and mortality. In the last few
years  patients who survived to burn injury has increased,
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but despite advances in the management of burn patients,
infections remain the most common cause of morbidity and
mortality  following burn injury.1,2
The mortality rate in burn centers varies depending on
different  factors, like age of patients, being the extremes
of  life more  vulnerable, and particularly the pediatric pop-
lsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDulation  aged less than four years. Furthermore, type and
mechanisms of burns have also been associated with
mortality.
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Full thickness burns, burns secondary to ﬂame associ-
ted  with inhalation injury have higher rate of infections and
ortality.1–5
Localization of burns in perineal area and face has
ncreased risk of mortality too.5
In developing countries mortality due to infections is very
igh  and an important risk factor to prevent.
The literature reporting on mortality risk associated with
urn  in childhood is scarce. Therefore, risk factors for mor-
ality  are not well known and strategies for their prevention
nd  the prompt referral of the patients to specialized centers
annot  be implemented.
The  aim of this study was  to evaluate epidemiological fea-
ures  and risk factors for mortality in cases of childhood burn
dmitted  in our tertiary hospital.
atients  and  methods
ll children with acute burns admitted to the Burn Center at
. P. Garrahan Hospital between June 2007 and December 2009
ere  included.
Type  of study: prospective and observational study. Patients
ere  followed prospectively during hospitalization and data
ollection  was  made through discharge or death.
eﬁnitions
ndependent  variables
(1) Gender: male–female.
(2)  Age in months.
(3)  Type of burn: superﬁcial (A), intermediate (AB), and “full-
thickness” or (B).
(4)  Mechanisms of burns: classiﬁed as: ﬂame, scalds,
inﬂammables liquids; explosion, and others mecha-
nisms.
(5)  Burn surface: Deﬁned as percentage of body according
Lund & Bowder chart.5
(6) Garcés′ Index: it is an index of prediction for mortality
and is calculated according the following formula6:
40 − age of patients + the percentage of burn body sur-
faces  for 1 (burn type A), for 2 (AB) or for 3 (B).
0–60 points: ﬁrst degree (low risk).
61–90: second degree (moderate risk).
91–120: third degree (severe risk).
≥121: fourth degree (critical).
(7) Invasive procedures: use of mechanical ventilation, cen-
tral  venous line, arterial and urinary catheters.
(8) Inhalation syndrome: suspected in facial burn, stridor,
and/or exposure to heavy smoke and conﬁrmed by endo-
scopic  examination.
(9)  Type of infections were deﬁned according to The Amer-
ican  Burn Association7 and based in clinical and/or
microbiological parameters.
10)  Positive blood culture.
11)  Type of microorganisms isolated in sterile material.
12) Use of colistin: in patients with documented infections
by multiple-resistant microorganisms only susceptible to
colistin  or, in some cases the use was  empirical, pending
culture results.4;1 8(2):144–149  145
(13)  Use of antifungal drugs.
(14)  Type of surgical treatment: scarectomy and graft require-
ment.
Dependent  variable
Mortality: mortality was  considered infection related if the
patient  had clinical and/or microbiological evidence of infec-
tion  at the time of death.
Microbiology
Cultures: blood cultures, wound cultures, and urine cultures
were  taken when appropriate according to clinical features.
Cultures  were performed according to the Clinical Lab-
oratory  Standard Institute (CLSI) methods. Susceptibility
testing was performed according to the CLSI using automated
methods.8
Multiresistant Pseudomonas spp. and Acinetobacter spp. were
deﬁned  as resistant to at least three classes of drugs (e.g.
beta-lactam antibiotics, carbapenems, aminoglycosides, and
ﬂuoroquinolones).
Treatment
Antibiotic treatment was  indicated in the presence of positive
cultures  and/or according to clinical features.
Statistical  analysis
Data were summarized in frequencies and percentages for
categorical  variables and as means and ranges (for continu-
ous  variables). The Mann–Whitney Rank Sum test was  used
to  assess differences between groups for two continuous
variables. Dichotomous variables were analyzed using the
Chi-square  test (with Yates correction). To estimate the
multivariate predictive value of independent covariates
for  mortality stepwise multiple logistic regression models
were  used (software in http://statpages.org/logistic.html)
including all signiﬁcant variables in univariate
analysis.
The predictive value for each covariant was  expressed as
the  relative risk (RR) and 95% conﬁdence interval. A p-value of
≤0.05  was  considered signiﬁcant for both sides.
This study was  approved by the Ethics committee of the
Hospital  J. P. Garrahan.
Results
Epidemiological  characteristics
We  included 110 patients.
The  median age of patients was 31.5 months (range: 1–204),
and  71 patients (65%) were  male.
Underlying diseases were  found in six patients (5%): genetic
syndrome in two patients, one metabolopathy, one oncohe-
matological disease, one cardiopathy, and one patient with
neurological disease.
Mechanism  of burns was ﬂame in 43 patients (39%); scalds,
31  patients (28%); inﬂammable liquids, 20 patients (18%);
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Table 1 – Characteristics of the patients (n: 110).
Variable n (p) % Median
Age (r: 1–204 months) 31.5 months
Male 71 66
Underlying diseases 6 5
Mechanism of burn
Flame  43 39
Scalds 31 28
Others 26 23
Burn surface (r: 1–95%) 27%
Garcés’ Index
1  14 13
2 39 35
3 24 22
4 33 30
Type of burns
A  39 36
AB 19 17
B 52 47
Inhalatory syndrome 52 47
Antibiotic prophylaxis 92 85
Venous catheter 90 82
Arterial catheter 83 75.5
Urinary catheter 86 78
Mechanical ventilation 75 68
Graft 82 (74.5)
Table 2 – Microbiologic features and foci (n: 128 foci in 84
patients).
Focus n (%) Germen n
Sepsis burn
related
48  (37) Gram negatives
Pseudomonas aeruginosa MR* 21
Acinetobacter sp. MR 20
Stenotrophomonas maltophilia 4
Enterobacter aglomerans 3
Escherichia coli 3
Serratia 2
Klebsiella pneumoniae 2
Burkhordelia 1
Non-fermenting (non
typeable)
1
Gram  positives
Meticilin R** S.aureus 8
Meticilin S*** S. aureus
Enterococcus faecium
5
Bacillus  spp. 6
Nocardia 1
Fungi
Candida albicans 5
Filamentoso sin tipiﬁcar 4
No albicans no tipiﬁcada 3
Candida guillermondie 2
Trichosporum asahi 2
Candida tropicalis 1
Candida lusitanae 1
Candida glabrata 1
Mucor 1
Wound
Infections
29 (23) Gram negatives
MR-Pseudomonas aeruginosa 9
MR-Acinetobacter spp. 5
Klebsiella spp. 2
Enterobacter aglomerans 1
Alcaligenes xiloxosidans 1
Gram positives
Meticilin R Stahylococcus
aureus
4
Meticilin  S. aureus 2
Bacillus sp. 3
Corynebacterium sp. 2
Enterococcus sp. 1
S.pyogenes 1
Fungi
Fusarium 5
Aspergillus fumigates 5
Alternaria sp. 3
Candida albicans 1
Candida tropícalis 3
Aureobasidium pullulans 1
Dreschelera 1
Filamentous non typeable 1
Penicilium 1
Mucor 1
Rodhotorula 1
Catheter
related
infections
11 (8.5) Gram negatives
MR  Pseudomonas aeruginosa 3Sepsis 48 (37)
explosion, 8 patients (7%); and other mechanisms, 8 patients
(8%).
Clinical  and  microbiological  features
Median burn surface affected was  27% (range 1–95%).
Garcés’ index was  1 in 14 patients (13%), 2 in 39 (35%), 3 in
24  (22%) and 4 in 33 (30%).
Type  of burn was: A in 39 patients (36%), AB in 19 (17%) and
B  in 52 (47%).
Localization of burn was  variable: head and face in 76
patients  (69%), trunk in 54 (49%), upper limb in 57 (52%), lower
limbs  in 45 (41%), hands in 16 (15%), perineal area in 6 (5.5%),
and  whole body except perineal area in 10 (9%) patients.
Inhalation syndrome was  present in 52 (47%) patients.
Ninety patients (82%) had indwelling venous catheters, 83
(75.5%)  patients arterial catheter and 86 (78%) patients urinary
catheters.
Seventy-ﬁve patients (68%) required mechanical ventila-
tion.
We  documented 128 infections in 84 patients being sepsis
related  to burn injury the most common.
Blood cultures were positive in 49 infections (38%).
Multiresistant Pseudomonas aeruginosa (52 infections) and
Acinetobacter spp. (29 infections) were isolated most frequently.
Colistin  was  used in 68 (62%) patients: empirical use in
28  (41%) and with multiresistant documented infection in 40
(59%)  patients.Antifungal was  used in 40 (36%) patients. Scarectomy was
required  in 90 (82%) patients and graft in 82 (74.5%).
(See Tables 1 and 2.)
MR  Acinetobacter sp.
Klebsiella  pneumoniae 1
Serratia marcescens 1
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Table 2 (Continued)
Focus n (%) Germen n
Alcaligenes xylosoxidans 1
Gram positives
Meticilin S- S. aureus 1
Enterococcus faecium 1
Bacillus sp. 1
Fungi 1
Candida albicans 3
Candida parapsilopsis 3
Candida no albicans 1
Urinary tract
infections
15  (12) Gram  negatives
Pseudomonas aeruginosa MR 7
Enterobacter aglomerans 2
Klebsiella pneumoniae 1
Acinetobacter spp. MR 1
Fungi
Candida albicans 3
Candida tropicalis 1
Ventilator
associated
pneumonia
8 (6) Gram negatives
Pseudomonas aeruginosa MR 6
Acinetobacter sp. MR 2
Klebsiella pneumoniae 1
Alcaligenes xylosoxidans 1
Gram positives
Meticilin R-S aureus 1
Fungi
Candida albicans 2
Osteomyelitis 5 (4) Meticilin R-S. aureus 2
Enteroccoccus faecalis 2
MR Pseudomonas aeruginosa 1
Pneumonia 4 (3) Streptococcus pneumoniae 1
Negative cultures 3
Corneal Abscess 3 (2) MR-Pseudomonas aeruginosa 3
Chondritis 2 (1.5) MR-Pseudomonas aeruginosa 2
Toxic Shock 1 (1) Streptococcus pyogenes 1
Endocarditis 1 (1) MR -Acinetobacter spp. 1
Zoster 1 (1) Varicella zoster Virus 1
∗ MR: multirresistant.
∗∗ R: Resistent.
∗∗∗ S: Susceptible.
Table 4 – Risk factors for mortality: multivariate analysis.
Variable RR (IC 95%) p
Age ≤4 years 24.34 (4.74–125) <0.0001
Garcés 4 9.4 (2.17–40.8) <0.003
Colistin use 4.2 (1.06–16.57) 0.04
Mechanical ventilation 11.32 (1.75–73) 0.011
Table 3 – Risk factors for mortality: bivariate analysis (n: 110, p)
Variable Death n (%) p Survivors n (%) p 
Age ≤4 years. 10 69 
Garcés 4 11 22 
Full thickness burn 13 39 
≥40% burn surface 12 26 
Inhalatory syndrome 12 40 
Venous catheter 17 73 
Arterial Catheter 17 66 
Urinary catheter 17 69 
Mechanical ventilation 17 58 
Positive blood cultures 12 37 
Colistin use 11 29 
Antifungal use 11 29 
Graft 9 73 Graft 0.04 (0.007–0.217) <0.0001
Evolution
Median length of stay was  37 days (range 1–139 days).
Seventeen patients (15%) died, 14 (82%) for infectious
related causes.
Independent risk factors for mortality were:  age ≤4 years,
Garcés  4, full thickness burn, ≥40% burn surface, inhalation
syndrome, venous catheter, arterial catheter, urinary catheter,
mechanical  ventilation, positive blood cultures, colistin use
in  documented multiresistant infections, antifungal use, and
graft  requirement. By multivariate analysis: age ≤4 years,
Garcés  4, colistin use in documented multiresistant infec-
tions,  and mechanical ventilation were independent variables
related  with mortality and graft requirement was  a protective
factor  for mortality. A comparison between survivors and non-
survivors  by univariate and multivariate analysis is shown in
Tables  3 and 4.
Discussion
Mortality in burn patients is an important complication and
studies  about risk factors in the pediatric population remained
poorly  delineated and scarce.1–5
Overall mortality rates in burn patients are variable ran-
ging  between 3.5% and 12%, depending on the extension of
the  burn, age of the patient and presence of multiple organ
failure.1
Fungal infection is an important cause of morbidity and
mortality in burn patients.1
There are a few reports in pediatrics burn patients.
A burn patient may  die because of different causes: shock
in  the ﬁrst hours post-burn, respiratory failure, usually sec-
ondary  to the inhalation syndrome; multiple organ failure
.
Total n (%) p RR (CI 95%) p
79 <0.0001
33 0.006
52 0.02
38 <0.0001
52 1.19 (1–1.42) 0.03
90 1.23 (1.12–1.36) 0.02
83 (75) 1.26 (1.13–1.41) 0.004
86 (78) 1.25 (1.12–1.39) 0.02
75 (68) 1.30 (1.15–1.47) 0.005
49 1.22 (1.02–1.45) 0.02
40 1.28 (1.03 –1.59) 0.03
40 1.26 (1.03–1.58) 0.008
82 0.03 0.63–1.03
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secondary to the extension and deepness of the burn wound,
among  others.
Nevertheless, in burn units infections and more  speciﬁcally
sepsis  are the most common cause of death.2,3
Pediatric burn patients are susceptible to a broad spectrum
of  infections which represent the most common and severe
complication in this population.9–16
Invasive procedures, misuse of antibiotics among others
are  key factors that in association with a susceptible host
due  to impaired immune system and loss of skin as the ﬁrst
defense  barriers facilitate infectious complications that may
lead  to death.
Awareness of risk factors related to increased mortal-
ity  in burn patients allow for extreme safety measures and
adequate  referral of patients to tertiary care centers to be
implemented.2,5
Gender was  not associated to mortality in our series, unlike
the  ﬁndings by O′Keefe et al.17 who reported increased mor-
tality  in adult women.
Age  less than four years has been considered as a major risk
factor  for mortality in children3,5,18 in line with our report.
A high Garcés’ score, particularly 4, was  signiﬁcantly asso-
ciated  with a higher risk of death; however, when this index
was  included in multivariate models with other parameters,
such  as age, deepness and burn surfaces it was  longer inde-
pendently  associated with mortality.
Type B, “full thickness” has been viewed as a risk factor by
several  authors,5,9 a ﬁnding that was  conﬁrmed in the present
study.
Inhalation syndrome is a clear and strong predictor of
mortality.3,5,9 In univariate analysis inhalation syndrome was
a  predictor of mortality in our patients but it signiﬁcance in
multivariate  analysis. Nevertheless, requirement of mechan-
ical  ventilation was  signiﬁcantly related with mortality and
may  indirectly reﬂect this condition in some cases.
Mechanical ventilation is clearly related with mortality in
other  studies.1–3
Majority of burn patients required invasive procedures
such as indwelling catheters frequently used in intensive care
units for resuscitation and ﬂuids and antibiotics administra-
tion  and/or urinary catheters, which are also associated with
increased  risk of infections and mortality.14 This ﬁnding was
conﬁrmed  by univariate analysis in our series.
Blood stream infection in burn patients has been previously
associated with mortality3 as it did in our series by univariate
analysis.
Infections complications are related with increased risk of
mortality  and the development of sepsis is a predictor of poor
outcome.2,3 Fourteen patients in our study died because of
sepsis.  Multiresistant Acinetobacter spp. and P. aeruginosa have
emerged  as important microorganisms in critical areas like
burn  units and are related with increased mortality in these
areas.19–21
A high proportion of infections in our study were  caused
by  Multiresistant P. aeruginosa and Acinetobacter spp.
Colistin, a bactericidal antibiotic, polymyxin derived, was
used  in the 1960s for the treatment of infections by Gram-
negative bacteria.
Because  of its side effects and the development of safer
drugs,  its use was  abandoned in the 1980s. The emergence 1 4;1  8(2):144–149
of multidrug resistant (MDR) Gram-negative bacteria and the
lack  of new antibiotics to combat them, have led to the revival
of  polymyxins.21–23
The use of Colistin in documented multiresistant infec-
tions  was  associated to mortality in our series. It is
possible that this association indirectly reﬂects the impact
of  multiresistant Gram-negative bacteria, although uni-
variate  and multivariate analyses did not show a rela-
tionship between type of infections, type of microorgan-
isms and mortality. However, presence of non-catheter
related positive blood cultures, and the use of colistin
in  documented multiresitant microorganisms should indi-
cate  an indirect correlation between this variables and
death.
Fungal  infection, not colonization, has been recognized
as an important cause of morbidity and mortality in burn
patients.1–26 However, fungal infection appears in more
severely injured patients with the high percentage of burned
body  surface, and if the wounds remained opened for
prolonged periods, the use of antibiotics and long hospi-
tal  stay could be related with the propensity to acquire
fungal infections.24 The use of antifungal drugs was  a
predictor of poor outcome in our patients by univariate
analysis, but not in multivariate analysis. Early surgical exci-
sion  and temporary or permanent closure with grafts are
important  measures for prevention of infections and related
deaths.3,26 In our series graft requirement was  a protec-
tive factor for mortality as pointed out in the literature but
scarectomy was not an independent variable related to mor-
tality.
In  the study by Dermijian5 to evaluate risk factors for mor-
tality,  burn surface greater than 40%, presence of inhalation
syndrome, location glutea or in perineal area, and inadequate
referral  of patients were independent risk factors for mortal-
ity.  In our series burn surface was a predictor for mortality but
the  location and inhalation syndrome were  not independently
associated with mortality in multivariate analysis. We  could
not  evaluate type of referral.
Mortality  rates reported in literature are lower than the rate
found  in our study,1–27 but a limitation of the present report is
that  the data were collected in a national tertiary referral cen-
ter  which may  have caused patient selection bias, including a
higher proportion of critically ill e patients.
Although the sample size in our study was  not large
enough to draw deﬁnitive conclusions for some of the studied
variables,  the ﬁndings are important due to the paucity of sys-
tematic  studies about this topic in children. Further research
is  necessary to support the data.
Knowledge of risk factors for mortality could be useful for
the  development of strategies to prevent this outcome which
together  with adequate referral to specialized centers will war-
rant  a better management of these vulnerable patients.
ConclusionAge ≤4 years, Garcés’ score 4, colistin use in documented
multiresistant infections, mechanical ventilation and graft
requirement were  independent variables associated with mor-
tality.
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